Associated Papers
Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors-Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?
Alen BO et al.
Cancers, 2022
35884384 (PubMed )
Supplement: cancers-14-03323-s001.zip › SUPPLEMENTARY_MATERIAL.xlsx › S5
Identifying Actionable Variants Using Capture-Based Targeted Sequencing in 563 Patients With Non-Small Cell Lung Carcinoma.
Jiang H et al.
Frontiers in Oncology, 2021
35186718 (PubMed )
Supplement: Table_1.xlsx › Supplementary_Table_2
Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
Choi JE et al.
Bmc Cancer, 2007
A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
Liu W et al.
Cancer Research, 2005
Select a paper to view details